Mitigating lung damage, mortality due to SARS-CoV-2

Researchers report that a drug approved for treating patients with autoimmune disease helped to prevent lung damage and death in mice infected with the SARS-CoV-2 virus, which causes COVID-19 in humans. Source

Leave a Reply

Your email address will not be published.